Insight

Erman Akkus: Hormone replacement therapy and colorectal cancer

Photo taken from salemwomensclinic.com

Jul 20, 2024, 21:28

Erman Akkus: Hormone replacement therapy and colorectal cancer

Erman Akkus, Medical Oncologist at Ankara University, shared on X:

“Hormone replacement therapy (estrogen plus progestin) and colorectal cancer WHI trial 24-year results

-No influence on CRC incidence
-No difference in CRC deaths

No clinically meaningful benefit (in contrast to fewer CRC reported in the first 5-year results).”

Estrogen Plus Progestin and Colorectal Cancer: Long-Term Findings From the Women’s Health Initiative Randomized Clinical Trial published in JCO

Authors: Rowan T. Chlebowski, Aaron K. Aragaki, Kathy Pan, Juhua Luo, Thomas E. Rohan, Karen C. Johnson, Jean Wactawski-Wende, Su Yon Jung, Qian Xiao, JoAnn E. Manson, and Michael S. Simon.

and colorectal cancer

Source: Erman Akkus/X

Aaron K. Aragaki and Michael S. Simon cancer colorectal cancer Erman Akkus Jean Wactawski-Wende JoAnn E. Manson Juhua Luo Karen C. Johnson Kathy Pan OncoDaily Oncology Qian Xiao Rowan T. Chlebowski Su Yon Jung Thomas E. Rohan

Esophageal Cancer: Symptoms, Causes, Stages, Diagnosis & Treatment

Faster, Flexible and Affordable: Mikhail Groubman on Building a Global Legacy in Clinical Research in an Untapped Market

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Special Coverage